Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05908825 · ClinicalTrials.gov registry record · NA
Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage in Adults
A NA study, sponsored by Austin Institute for Clinical Research.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT05908825 is a NA study that has completed, run by Austin Institute for Clinical Research. The registered enrollment target is 34 participants.
The verdict
NCT05908825, a NA study, has completed, sponsored by Austin Institute for Clinical Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
This is a split-face, double-blind, placebo-controlled study assessing the use of a novel exfoliative serum with a chemical peel to improve photodamage in healthy female subjects between the ages of 30 and 65 years, inclusive, with Fitzpatrick skin types I-VI.
Interventions
- DRUG Vitamin C with AHA Exfoliative Serum
- DRUG Placebo serum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2023-06-22 |
| Est. Completion | 2024-01-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05908825
The ClinicalTrials.gov registry entry for NCT05908825 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Austin Institute for Clinical Research, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitamin C with AHA Exfoliative Serum is the first listed.
NCT05908825 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05908825 about?
NCT05908825 is a clinical study titled "Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage in Adults". This is a split-face, double-blind, placebo-controlled study assessing the use of a novel exfoliative serum with a chemical peel to improve photodamage in healthy female subjects between the ages of 30 and 65 years, inclusive, with Fitzpatrick skin types I-VI.
What is the current status of trial NCT05908825?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2023-06-22. Estimated completion is 2024-01-26.
What interventions are being tested in trial NCT05908825?
The interventions under investigation include: Vitamin C with AHA Exfoliative Serum (DRUG), Placebo serum (DRUG).
Who is sponsoring clinical trial NCT05908825?
This trial is sponsored by Austin Institute for Clinical Research, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.